Records containing: Rheumatoid Arthritis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-09-03American College of Rheumatology's Rheumatology Informatics System for Effectiveness
-
CLINICAL_TRIALS study record update · 2014-09-03Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2014-09-03The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment
-
CLINICAL_TRIALS study record update · 2014-09-01American College of Rheumatology Clinical Registry
-
CLINICAL_TRIALS study record update · 2014-08-28Monitoring EBV Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs ; Orencia* (Abatacept) and RoActemra* (Tocilizumab).
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-08-21FK506 Phase 4 Study: A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients
-
CLINICAL_TRIALS study record update · 2014-08-15A Randomised, Active Comparator, Double-blind, Multi Centre, Parallel, Phase 2a Trial, Investigating the Mechanism of Action, of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
-
CLINICAL_TRIALS study record update · 2014-08-15A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
-
CLINICAL_TRIALS study record update · 2014-08-13Evaluation of Adherence and Persistence to Tocilizumab in Combination With Methotrexate or Tocilizumab Monotherapy in Patients With Moderate to Severe Active Rheumatoid Arthritis in Local Environment.
-
CLINICAL_TRIALS study record update · 2014-08-12A Single Arm, Open-label Study of Early Improvement of Anemia and Fatigue During Treatment With Tocilizumab (TCZ) in Combination With DMARDs, in Adult Patients With Moderate to Severe Active Rheumatoid Arthritis.
-
CLINICAL_TRIALS study record update · 2014-08-07International Multi-Center Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have An Inadequate Response to Current Non-Biologic DMARD or Anti-TNF Therapy.
-
CLINICAL_TRIALS study record update · 2014-08-06An Extension Phase of the Multi-National Open-Label Study (MA21573) to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have an Inadequate Response to Current Non-biologic DMARD and/or Anti-TNF Therapy.
-
CLINICAL_TRIALS study record update · 2014-08-05Long-term Safety and Efficacy of Etanercept in a UK Observational Cohort Study - a Retrospective Database Analysis of British Society of Rheumatology Biologics Registry (BSRBR) Data
-
CLINICAL_TRIALS study record update · 2014-08-05Rituximab Phase IIIb Open-label, Multi-centre Assessment of Safety and Effectiveness in Patients With RA Following an Inadequate Response to One Prior Anti-TNF Inhibitor (RESET)
-
CLINICAL_TRIALS study record update · 2014-08-04An Open Label Study to Evaluate the Safety, and Effect on Treatment Response, of MabThera in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response or Intolerance to One or More Anti-TNF Agents.
-
CLINICAL_TRIALS study record update · 2014-08-04A Single-arm, Open-label, Multicenter Study of Tocilizumab Monotherapy or in Combination With Methotrexate to Assess Safety and the Efficacy in Reducing Disease Activity in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs (PICTURE)
-
CLINICAL_TRIALS study record update · 2014-07-29Multi-center, Prospective, Clinical Evaluation of Pinnacle Acetabular Implants in Total Hip Arthroplasty
-
CLINICAL_TRIALS study record update · 2014-07-28Rheumatoid Arthritis in Greece: The Economic Burden of the Disease and the Impact on Quality of Life
-
CLINICAL_TRIALS study record update · 2014-07-22Multicenter, Open-Label Study to Evaluate the Safety, Tolerability and the Effect on Disease Activity of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have an Inadequate Response to Current Non-biologic DMARD and/or Anti- TNF Therapy.
-
CLINICAL_TRIALS study record update · 2014-07-22Evaluation of Grip Strength With Digitized Sensor in Adults With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2014-07-18Randomized Placebo-controlled Study of Two Treatment Strategies Based on Tocilizumab (TCZ) With or Without Methotrexate (MTX) and Possible Addition of Other Disease-modifying Anti-rheumatic Drugs (DMARDs) in Patients...
-
CLINICAL_TRIALS study record update · 2014-07-18Effect of Moderate to High Intensity Aerobic Interval Training on Polysomnographic Measured Sleep in Patients With Rheumatoid Arthritis. A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2014-07-17Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)
-
CLINICAL_TRIALS study record update · 2014-07-17A 3-Phase Study to Evaluate Sustained Remission and Productivity Outcomes in Subjects With Early Rheumatoid Arthritis Initiated on Treatment With Etanercept Plus Methotrexate
-
CLINICAL_TRIALS study record update · 2014-07-16An Open-label, Exploratory Study of the Pharmacokinetic and Pharmacodynamic Activity of MabThera in Combination With Methotrexate in Synovial Tissue and in Peripheral Blood of Patients With Active Rheumatoid Arthritis.